[Agranulocytosis after use of aprindine (Fiboran)].
D000368:Aged; D000380:Agranulocytosis / Q000139:chemically induced*; D001073:Aprindine / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007192:Indenes / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy
D007192:Indenes; D001073:Aprindine
Agranulocytose na aprindine (Fiboran)-gebruik